Japan Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Published : Aug-2017

No. of Pages : 122

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Drug Delivery Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Drug Delivery Devices Market, Japan 11
3.1 Drug Delivery Devices Market, Japan, Revenue ($m), 2009-2023 11
3.2 Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2016 13
3.3 Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2016 14
3.4 Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023 15
3.5 Drug Delivery Devices Market, Japan, Revenue ($m), 2009-2016 17
3.6 Drug Delivery Devices Market, Japan, Revenue ($m), 2016-2023 19
3.7 Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023 21
3.8 Drug Delivery Devices Market, Japan, Volume (Units), 2009-2016 23
3.9 Drug Delivery Devices Market, Japan, Volume (Units), 2016-2023 25
3.10 Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), 2016 27
4 Central Venous Catheters Market, Japan 29
4.1 Central Venous Catheters Market, Japan, Revenue Mix ($m), 2016 29
4.2 Central Venous Catheters Market, Japan, Segment Contribution (%), 2016 30
4.3 Central Venous Catheters Market, India, Revenue ($m), 2009-2016 31
4.4 Central Venous Catheters Market, India, Revenue ($m), 2016-2023 33
4.5 Central Venous Catheters Market, India, Volume (Units), 2009-2016 35
4.6 Central Venous Catheters Market, India, Volume (Units), 2016-2023 37
4.7 Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2015-2016 39
4.8 Central Venous Catheters Market, India, Company Share by Revenue ($m), 2016 40
5 Infusion Systems Market, Japan 42
5.1 Infusion Systems Market, Japan, Revenue Mix ($m), 2016 42
5.2 Infusion Systems Market, Japan, Segment Contribution (%), 2016 43
5.3 Infusion Systems Market, Japan, Revenue ($m), 2009-2016 44
5.4 Infusion Systems Market, Japan, Revenue ($m), 2016-2023 46
5.4.1 Ambulatory Infusion Pumps Market, Japan, Revenue ($m), by Segment, 2009-2016 48
5.4.2 Syringe Pumps Market, Japan, Revenue ($m), by Segment, 2009-2016 50
5.4.3 Ambulatory Infusion Pumps Market, Japan, Revenue ($m), by Segment, 2016-2023 52
5.4.4 Syringe Pumps Market, Japan, Revenue ($m), by Segment, 2016-2023 54
5.5 Infusion Systems Market, Japan, Volume (Units), 2009-2016 56
5.6 Infusion Systems Market, Japan, Volume (Units), 2016-2023 58
5.6.1 Ambulatory Infusion Pumps Market, Japan, Volume (Units), by Segment, 2009-2016 60
5.6.2 Syringe Pumps Market, Japan, Volume (Units), by Segment, 2009-2016 62
5.6.3 Ambulatory Infusion Pumps Market, Japan, Volume (Units), by Segment, 2016-2023 64
5.6.4 Syringe Pumps Market, Japan, Volume (Units), by Segment, 2016-2023 66
5.7 Infusion Systems Market, Japan, Distribution Share by Revenue ($m), 2015-2016 68
5.8 Infusion Systems Market, Japan, Company Share by Revenue ($m), 2016 69
6 Needle Free Injections Market, Japan 71
6.1 Needle Free Injections Market, Japan, Revenue ($m), 2009-2016 71
6.2 Needle Free Injections Market, Japan, Revenue ($m), 2016-2023 72
6.3 Needle Free Injections Market, Japan, Volume (Units), 2009-2016 73
6.4 Needle Free Injections Market, Japan, Volume (Units), 2016-2023 74
6.5 Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), 2015-2016 75
6.6 Needle Free Injections Market, Japan, Company Share by Revenue ($m), 2016 76
7 Metered Dose Inhaler Devices Market, Japan 78
7.1 Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2009-2016 78
7.2 Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2016-2023 79
7.3 Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2009-2016 80
7.4 Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2016-2023 81
7.5 Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), 2015-2016 82
7.6 Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), 2016 83
8 Overview of Key Companies in Japan, Drug Delivery Devices Market 85
8.1 Terumo Corp 85
8.1.1 Company Overview 85
8.2 GlaxoSmithKline Plc 85
8.2.1 Company Overview 85
8.3 Teleflex Inc 85
8.3.1 Company Overview 85
8.4 AstraZeneca Plc 85
8.4.1 Company Overview 85
8.5 Boehringer Ingelheim GmbH 86
8.5.1 Company Overview 86
8.6 Pfizer Inc 86
8.6.1 Company Overview 86
8.7 Merck & Co Inc 86
8.7.1 Company Overview 86
8.8 B. Braun Melsungen AG 86
8.8.1 Company Overview 86
8.9 Nipro Corp 87
8.9.1 Company Overview 87
8.10 Baxter International Inc 87
8.10.1 Company Overview 87
8.11 Smiths Medical 87
8.11.1 Company Overview 87
8.12 Becton Dickinson and Co 87
8.12.1 Company Overview 87
8.13 Hospira Inc 88
8.13.1 Company Overview 88
8.14 Fresenius Kabi AG 88
8.14.1 Company Overview 88
8.15 Medtronic plc 88
8.15.1 Company Overview 88
9 Drug Delivery Devices Market Pipeline Products 89
10 Financial Deals Landscape 94
10.1 Asset Transactions 94
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
10.2 Equity Offerings 96
10.2.1 Solasia Pharma to Raise USD31.9 Million in IPO 96
10.3 Partnerships 98
10.3.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 98
10.3.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 99
10.3.3 Terumo to Enter into Agreement with Phosphagenics 101
10.3.4 Pfizer Terminates its Licensing Agreement with pSivida 102
10.3.5 Bayer Enters into Licensing Agreement with DelSiTech 103
10.3.6 BioCorRx Enters into Licensing Agreement with Therakine 104
11 Recent Developments 105
11.1 Corporate Communications 105
11.1.1 Jun 16, 2017: Sumitomo Dainippon Pharma announces personnel change 105
11.1.2 May 08, 2017: Sumitomo Dainippon Pharma announces personnel change 105
11.1.3 Mar 29, 2017: Sumitomo Dainippon Pharma announces Changes in Executive Officers 105
11.1.4 Mar 22, 2017: Sumitomo Dainippon Pharma Announces New Chief Executive Officer at Boston Biomedical and Establishment of Global Head of Oncology 105
11.1.5 Feb 24, 2017: Daiichi Sankyo Appoints New Group Corporate Officers 106
11.1.6 Feb 24, 2017: Sumitomo Dainippon Pharma announces Changes of Representative Directors and Executive Officers 107
11.1.7 Feb 09, 2017: Terumo Announces Change of Executive Officers 107
11.1.8 Jan 31, 2017: Daiichi Sankyo Announces New Chairman and President 108
11.1.9 Nov 11, 2016: Sumitomo Dainippon Pharma Announces Organizational Realignment and Changes Related to Officers and Other Key Positions 108
11.1.10 Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development 109
11.2 Financial Announcements 109
11.2.1 Jul 29, 2016: Summary of Consolidated Financial Results For the First Quarter of the Fiscal Year Ending March 31, 2017 109
11.3 Government and Public Interest 111
11.3.1 Jul 11, 2017: Daiichi Sankyo Selected for Ninth Consecutive Year as Constituent of FTSE4Good Global Index by FTSE Russell 111
11.3.2 Jul 03, 2017: 15th Takamine Memorial Daiichi Sankyo Prize Winner Announced 111
11.4 Legal And Regulatory 112
11.4.1 Jul 04, 2017: Sumitomo Dainippon Pharma Announces Change in Name of Consolidated Subsidiary Based in U.S. 112
11.5 Other Significant Developments 112
11.5.1 Apr 27, 2017: Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibody Drug Conjugate Portfolio 112
11.5.2 Jan 26, 2017: Achievement of sales milestone for COPD products 113
11.5.3 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System 113
11.5.4 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 113
11.6 Product News 114
11.6.1 Jun 12, 2017: Aptar Pharma Extends its Child-Resistant Nasal Pump Manufacturing Capabilities in North America 114
11.6.2 Jan 30, 2017: Terumo launches user friendly PLAJEX Luer Lock with Threaded Closure (TC) 114
11.6.3 Jan 26, 2017: Terumo and Nemera announce compatibility between PLAJEX polymer prefillable syringes and Safe'n'Sound 114
11.7 Strategy And Business Planning 115
11.7.1 Feb 24, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2017 115
11.7.2 Feb 15, 2017: Daiichi Sankyo Strengthens Authorized Generic Business through Daiichi Sankyo Espha 116
11.7.3 Feb 10, 2017: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure 116
11.7.4 Jan 31, 2017: Terumo Opens a Branch in Yangon 117
12 Appendix 118
12.1 Research Methodology 119
12.1.1 Coverage 119
12.1.2 Secondary Research 119
12.1.3 Primary Research 120
12.1.4 Company Share Analysis 120
12.1.5 Distribution Share Analysis 120
12.1.6 Benchmarking 121
12.2 GlobalData Consulting 121
12.3 Contact Us 122
12.4 Disclaimer 122

1.1 List of Tables
Table 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2009-2023 12
Table 2: Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2016 14
Table 3: Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023 16
Table 4: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 18
Table 5: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 20
Table 6: Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023 22
Table 7: Drug Delivery Devices Market, Japan, Volume (Units), Historic, 2009-2016 24
Table 8: Drug Delivery Devices Market, Japan, Volume (Units), Forecast, 2016-2023 26
Table 9: Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 28
Table 10: Central Venous Catheters Market, Japan, Segment Contribution (%), 2016 30
Table 11: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 32
Table 12: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 34
Table 13: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 36
Table 14: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 38
Table 15: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39
Table 16: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2016 41
Table 17: Infusion Systems Market, Japan, Segment Contribution (%), 2016 43
Table 18: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 45
Table 19: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 47
Table 20: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 49
Table 21: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 51
Table 22: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 53
Table 23: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 55
Table 24: Infusion Systems Market, Japan, Volume (Units), Historic, 2009-2016 57
Table 25: Infusion Systems Market, Japan, Volume (Units), Forecast, 2016-2023 59
Table 26: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Historic, 2009-2016 61
Table 27: Syringe Pumps Market, Japan, Volume (Units), Historic, 2009-2016 63
Table 28: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Forecast, 2016-2023 65
Table 29: Syringe Pumps Market, Japan, Volume (Units), Forecast, 2016-2023 67
Table 30: Infusion Systems Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016 68
Table 31: Infusion Systems Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 70
Table 32: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 71
Table 33: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 72
Table 34: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016 73
Table 35: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023 74
Table 36: Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016 75
Table 37: Needle Free Injections Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 77
Table 38: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 78
Table 39: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 79
Table 40: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016 80
Table 41: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023 81
Table 42: Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016 82
Table 43: Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 84
Table 44: Drug Delivery Devices Market Pipeline Products 89
Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
Table 46: Solasia Pharma to Raise USD31.9 Million in IPO 96
Table 47: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 98
Table 48: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 99
Table 49: Terumo to Enter into Agreement with Phosphagenics 101
Table 50: Pfizer Terminates its Licensing Agreement with pSivida 102
Table 51: Bayer Enters into Licensing Agreement with DelSiTech 103
Table 52: BioCorRx Enters into Licensing Agreement with Therakine 104

1.2 List of Figures
Figure 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2009-2023 11
Figure 2: Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2016 13
Figure 3: Drug Delivery Devices Market, Japan, Category Contribution (%), 2016 14
Figure 4: Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023 15
Figure 5: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 17
Figure 6: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Figure 7: Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023 21
Figure 8: Drug Delivery Devices Market, Japan, Volume (Units), Historic, 2009-2016 23
Figure 9: Drug Delivery Devices Market, Japan, Volume (Units), Forecast, 2016-2023 25
Figure 10: Drug Delivery Devices Market, Japan, Company Share (%) 2016 27
Figure 11: Central Venous Catheters Market, Japan, Revenue Mix ($m), 2016 29
Figure 12: Central Venous Catheters Market, Japan, Segment Contribution (%), 2016 30
Figure 13: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 31
Figure 14: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 33
Figure 15: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 35
Figure 16: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 37
Figure 17: Central Venous Catheters Market, India, Company Share (%) 2016 40
Figure 18: Infusion Systems Market, Japan, Revenue Mix ($m), 2016 42
Figure 19: Infusion Systems Market, Japan, Segment Contribution (%), 2016 43
Figure 20: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 44
Figure 21: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 46
Figure 22: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 48
Figure 23: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 50
Figure 24: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 52
Figure 25: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 54
Figure 26: Infusion Systems Market, Japan, Volume (Units), Historic, 2009-2016 56
Figure 27: Infusion Systems Market, Japan, Volume (Units), Forecast, 2016-2023 58
Figure 28: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Historic, 2009-2016 60
Figure 29: Syringe Pumps Market, Japan, Volume (Units), Historic, 2009-2016 62
Figure 30: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Forecast, 2016-2023 64
Figure 31: Syringe Pumps Market, Japan, Volume (Units), Forecast, 2016-2023 66
Figure 32: Infusion Systems Market, Japan, Company Share (%) 2016 69
Figure 33: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 71
Figure 34: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 72
Figure 35: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016 73
Figure 36: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023 74
Figure 37: Needle Free Injections Market, Japan, Company Share (%) 2016 76
Figure 38: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 78
Figure 39: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 79
Figure 40: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016 80
Figure 41: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023 81
Figure 42: Metered Dose Inhaler Devices Market, Japan, Company Share (%) 2016 83

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Japan Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027